Similarly, Momchilova et al. showed that resveratrol treatment (50 μM) significantly reduced ceramide levels by activating neutral sphingomyelinase (nSMase) in plasma membranes of hepatocytes isolated from aged rats though not in metabolic disease model [78]. This evidence concerns the gene SMPD2 and metabolic disease.